MedTrace Logo

Words Generation in Compulsives Gamblers and Parkinson's Disease Patients

NCT01888276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2015-06-11

No results posted yet for this study

Summary

The pathophysiology of compulsive disorders as gambling could be close to behavior problems encountered in Parkinson's disease associated with a hyperactivity of the motivational system.

Thanks to the words generation test, which reflects the cortico-subcortical loop functioning, involved in motivation, we want to evaluate and compare using tools (words generation and behavioral tests) the motivational functioning of gamblers and healthy volunteers that we can then compare to that of Parkinson's patients with and without behavioral hyperdopaminergic disorders which were explored in another study.

Conditions

  • Parkinson Disease

Interventions

OTHER

evaluation of word generation and of motivation

Each subject will realize twice each test during 2 sessions with one hour in between : During the session 1 : * The test of words generation, which is to produce action verbs in response to 40 nouns, and noun in response to verbs. * The test of Stroop that assesses selective attention During the session 2: * The test of words generation, which is to produce action verbs in response to 40 nouns, and noun in response to verbs. * The task of the casino (Iowa Gambling Test) * The task of landing * The test of Stroop

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Christine Brefel, MD · UH Toulouse

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888276 on ClinicalTrials.gov